The question remains open whether there is such a systemic factor that affects the adiponectin levels in patients with arthritis or whether the joint disease itself rather than BMI might be a greater explanatory factor in defining the adiponectin levels in these patients. The gene discussed is ADIPOQ; the disease is arthritic joint disease.